Cargando…
A novel human laboratory model for screening medications for alcohol use disorder
BACKGROUND: Alcohol use disorder (AUD) is a highly prevalent, chronic relapsing disorder with a high disease burden in the USA. Pharmacotherapy is a promising treatment method for AUD; however, the few FDA-approved medications are only modestly effective. Medications development for AUD is a high pr...
Autores principales: | Ho, Diana, Towns, Brandon, Grodin, Erica N., Ray, Lara A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681966/ https://www.ncbi.nlm.nih.gov/pubmed/33225963 http://dx.doi.org/10.1186/s13063-020-04842-w |
Ejemplares similares
-
Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial
por: Burnette, Elizabeth M., et al.
Publicado: (2020) -
Translational opportunities in animal and human models to study alcohol use disorder
por: Nieto, Steven J., et al.
Publicado: (2021) -
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
por: Burnette, Elizabeth M., et al.
Publicado: (2022) -
Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial
por: Grodin, Erica N., et al.
Publicado: (2021) -
Protocol for a mobile laboratory study of co-administration of cannabis concentrates with a standard alcohol dose in humans
por: Karoly, Hollis C., et al.
Publicado: (2022)